Filing Details

Accession Number:
0001209191-20-054326
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-08 18:35:21
Reporting Period:
2020-10-06
Accepted Time:
2020-10-08 18:35:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671818 Oncorus Inc. ONCR Pharmaceutical Preparations (2834) 473779757
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765022 Mpm Sunstates Fund, L.p. C/O Mpm Asset Management Llc
450 Kendall Street
Cambridge MA 02142
No No Yes No
1765023 Mpm Sunstates Gp Managing Member Llc C/O Mpm Asset Management Llc
450 Kendall Street
Cambridge MA 02142
No No Yes No
1765025 Mpm Asset Management Investors Sunstates Fund Llc C/O Mpm Asset Management Llc
450 Kendall Street
Cambridge MA 02139
No No Yes No
1765026 Mpm Sunstates Fund Gp Llc C/O Mpm Asset Management Llc
450 Kendall Street
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-06 1,783,879 $0.00 1,899,702 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-10-06 775,975 $0.00 2,675,677 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-10-06 173,776 $15.00 2,849,453 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Preferred Stock Disposition 2020-10-06 1,783,879 $0.00 1,783,879 $0.00
Common Stock Series B Preferred Stock Disposition 2020-10-06 775,975 $0.00 775,975 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A-1 Preferred and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of theIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
  2. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
  3. The shares are held as follows: 1,382,943 by MPM BioVentures 2014, L.P. ("BV 2014"), 92,239 by MPM BioVentures 2014(B), L.P. ("BV2014(B)"), 50,164 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"), 224,924 by MPM Sunstates Fund, L.P. ("MPMSunStates"), 33,609 by MPM Asset Management Investors Sunstates Fund LLC ("AM SunStates") and 115,823 by MPM Asset ManagementLLC ("AM LLC"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV2014 and BV 2014(B). BV LLC is the manager of AM BV2014. MPM SunStates Fund GP LLC and MPM SunStates GP Managing Member LLC("SunStates GP") are the direct and indirect general partners of MPM SunStates. SunStates GP is the manager of AM SunStates. Luke Evnin,Ansbert Gadicke and Todd Foley are the managing directors of BV LLC, Luke Evnin and Anbsert Gadicke are the members of AM LLC andAnsbert Gadicke is a member of SunStates GP.
  4. The shares are held as follows: 2,018,001 by BV 2014, 134,595 by BV 2014(B), 73,199 by AM BV2014, 290,632 by MPM SunStates, 43,427 byAM SunStates and 115,823 by AM LLC.
  5. The shares are held as follows: 2,155,108 by BV 2014, 143,740 by BV 2014(B), 78,172 by AM BV2014, 310,251 by MPM SunStates, 46,359 byAM SunStates and 115,823 by AM LLC.
  6. The shares are held as follows: 1,382,943 by BV 2014, 92,239 by BV 2014(B), 50,164 by AM BV2014, 224,924 by MPM SunStates and 33,609 by AM SunStates.
  7. The shares are held as follows: 635,058 by BV 2014, 42,356 by BV 2014(B), 23,035 by AM BV2014, 65,708 by MPM SunStates and 9,818 by AM SunStates.